Usama Dar appointed as chief product and technology officer at CluePoints

April 2, 2025
Research and Development Pharmacy, clinical trial analysis, cluepoints, pharma, research and development

CluePoints has appointed Usama Dar as its new chief product and technology officer, effective 1 April 2025. This follows Dar’s …

Dupixent approved as first biologic medicine in Japan for COPD patients

April 2, 2025
Research and Development COPD, Chronic Diseases, Regeneron, Sanofi, biotech, respiratory disease

The Ministry of Health, Labour and Welfare in Japan has authorised marketing and manufacturing of Dupixent (dupilumab) for the treatment …

biology-think-networking-physiology-brain-anatomy-2676370

ADHD coach and breathwork experts to run workshop for ADHD management

April 2, 2025
Design & Creative, Freelancers ADHD, Neurology, healthcare, mental health, nervous system

ADHD coach John Harrington and breathwork facilitator Martin O’Toole will collaborate on ‘Breathwork for ADHD and Beyond’, a breathwork-orientated session …

Rybelsus found to reduce major adverse cardiovascular events in Novo Nordisk trial

April 1, 2025
Research and Development Cardiology, Novo Nordisk, cardiometabolic diseases, research and development

Novo Nordisk announced results from its SOUL cardiovascular outcomes trial. Rybelsus (oral semaglutide) significantly reduced the risk of major adverse …

Corcept’s relacorilant trial in patients with platinum-resistant ovarian cancer meets primary endpoint

April 1, 2025
Research and Development Corcept Therapeutics, Oncology, ovarian cancer, research and development

Corcept Therapeutics announced that relacorilant plus nab-paclitaxel met its primary endpoint of improved progression-free survival in ROSELLA, the company’s phase …

Secarna Pharmaceuticals to announce positive new data at cancer research conference

April 1, 2025
Research and Development Oncology, Secarna Pharmaceuticals, oncology, research and development

Secarna Pharmaceuticals will present new preclinical data with its lead programme SECN-15 at the American Association for Cancer Research (AACR) …

Qfitlia approved by FDA to treat haemophilia A or B

March 31, 2025
Research and Development FDA, Haematology, Sanofi, haemophilia, pharma

The US Food and Drug Administration (FDA) has approved Qfitlia (fitusiran) as the first therapy in the US to treat …

Alfred Merz appointed as CEO of ProBioGen

March 31, 2025
Manufacturing Services, Manufacturing and Production CEO, Pharmacy, ProBioGen, appointment, biotech

ProBioGen has announced the appointment of Alfred Merz as its chief executive officer (CEO), effective 1 April 2025. Merz, who …

hsm_mobile_clinical_trial_istock-872676342

Medidata launches programme to accelerate therapy delivery

March 31, 2025
Market Research Medidata, Pharmacy, pharma, technology

Medidata has announced the launch of its Medidata Site Insights Program – a collection of initiatives intended to foster more …

Winners announced for 2025 PM Society Awards

March 31, 2025
Industry Associations, Research and Development Pharmacy, awards, pharma industry, pm society

The pharma marketing and healthcare communications industry gathered for the 39th PM Society Awards on 14 March 2025, which celebrates …

FDA grants fast track designation to chlamydia vaccine candidate

March 28, 2025
Research and Development FDA, Infections and infestations, Sanofi, chlamydia, vaccination

The US Food and Drug Association (FDA) has granted fast track designation to Sanofi’s mRNA vaccine candidate for the prevention …

Shane Olwill appointed as chief development officer at Asgard Therapeutics

March 28, 2025
Business Services, Clinical Research Asgard Therapeutics, CDO, Oncology, appointment, immunology

Asgard Therapeutics has announced the appointment of Shane Olwill as chief development officer (CDO). The biotech company develops in vivo …

Gergely Sved appointed as CEO of Ellab

March 28, 2025
Contract Sales Organisations, Sales and Marketing CEO, Ellab, Pharmacy, appointment, life sciences

Ellab has announced that it has appointed Gergely Sved as its new chief executive officer (CEO). The company provides validation, …

Carole Imbert appointed as CFO of Vect-Horus

March 28, 2025
Biotech/start-up, Sales and Marketing Pharmacy, Vect-Horus, appointment, biotech, cfo

Vect-Horus has announced it has appointed Carole Imbert as chief financial officer (CFO) and to its executive committee. Vect-Horus is …

Five of EU-27 account for 68% of pharma trade, report finds

March 27, 2025
Market Research Logista Freight, Pharmacy, european union, market report, trade

Logista Freight has found that Germany, France, Belgium, Italy and the Netherlands account for up to 68% of trade in …

lungs

Pierre Fabre announces investments and partnerships in lung cancer research

March 27, 2025
Research and Development Oncology, Pierre Fabre Laboratories, lung cancer treatment, oncology

Pierre Fabre Laboratories has announced investment and partnership plans to improve the lives of lung cancer patients with unmet needs. …

Allegro shares promising preclinical results for osteoarthritis treatment

March 26, 2025
Clinical Trial Services, Research and Development Allegro, Orthopaedics, biomedical, clinical studies, osteoarthritis

Allegro has announced that hydrocelin, its injectable microparticle hydrogel, showed no signs of toxicity in two preclinical studies. Allegro is …

Pharming Group doses first patient in phase 2 trial of leniolisib in CVID

March 26, 2025
Clinical Trial Services, Research and Development CVID, Immunology, Pharming Group, clinical trial, common variable immunodeficiency, immunodeficiency

Pharming Group has announced that the first patient has been dosed in a phase 2 clinical trial evaluating leniolisib in …

handshake_2

Cold Chain Technologies acquires Global Cold Chain Solutions

March 26, 2025
Dedicated cold-chain delivery, Manufacturing and Production Global Cold Chain Solutions, Pharmacy, business development, cold chain, life sciences, partnership

Cold Chain Technologies (CCT), a global provider for temperature-sensitive packing and digital solutions, has acquired Global Cold Chain Solutions (GCCS), …

Gary Lyons appointed as EVP medical affairs of Coronado Research

March 26, 2025
Business Services, Consultancy Consultancy, Coronado Research, Medical Affairs, Pharmacy, appointment

Coronado Research, a UK-based consultancy-led organisation, has announced that it has appointed Gary Lyons as executive vice president (EVP) for …

The Gateway to Local Adoption Series

Latest content